212 related articles for article (PubMed ID: 23755832)
1. Cancer cell-specific photoactivity of pheophorbide a-glycol chitosan nanoparticles for photodynamic therapy in tumor-bearing mice.
Oh IH; Min HS; Li L; Tran TH; Lee YK; Kwon IC; Choi K; Kim K; Huh KM
Biomaterials; 2013 Sep; 34(27):6454-63. PubMed ID: 23755832
[TBL] [Abstract][Full Text] [Related]
2. GSH-mediated photoactivity of pheophorbide a-conjugated heparin/gold nanoparticle for photodynamic therapy.
Li L; Nurunnabi ; Nafiujjaman ; Lee YK; Huh KM
J Control Release; 2013 Oct; 171(2):241-50. PubMed ID: 23867285
[TBL] [Abstract][Full Text] [Related]
3. Biarmed poly(ethylene glycol)-(pheophorbide a)2 conjugate as a bioactivatable delivery carrier for photodynamic therapy.
Kim WL; Cho H; Li L; Kang HC; Huh KM
Biomacromolecules; 2014 Jun; 15(6):2224-34. PubMed ID: 24805286
[TBL] [Abstract][Full Text] [Related]
4. Bioreducible branched polyethyleneimine derivatives physically loaded with hydrophobic pheophorbide A: preparation, characterization, and light-induced cytotoxicity.
Cho H; Li L; Bae YH; Huh KM; Kang HC
Macromol Biosci; 2014 Oct; 14(10):1483-94. PubMed ID: 25130538
[TBL] [Abstract][Full Text] [Related]
5. Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system.
Lee SJ; Koo H; Lee DE; Min S; Lee S; Chen X; Choi Y; Leary JF; Park K; Jeong SY; Kwon IC; Kim K; Choi K
Biomaterials; 2011 Jun; 32(16):4021-9. PubMed ID: 21376388
[TBL] [Abstract][Full Text] [Related]
6. Specific light-up pullulan-based nanoparticles with reduction-triggered emission and activatable photoactivity for the imaging and photodynamic killing of cancer cells.
Xia J; Zhang L; Qian M; Bao Y; Wang J; Li Y
J Colloid Interface Sci; 2017 Jul; 498():170-181. PubMed ID: 28324723
[TBL] [Abstract][Full Text] [Related]
7. Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice.
Lee SJ; Park K; Oh YK; Kwon SH; Her S; Kim IS; Choi K; Lee SJ; Kim H; Lee SG; Kim K; Kwon IC
Biomaterials; 2009 May; 30(15):2929-39. PubMed ID: 19254811
[TBL] [Abstract][Full Text] [Related]
8. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
9. Effect of the stability and deformability of self-assembled glycol chitosan nanoparticles on tumor-targeting efficiency.
Na JH; Lee SY; Lee S; Koo H; Min KH; Jeong SY; Yuk SH; Kim K; Kwon IC
J Control Release; 2012 Oct; 163(1):2-9. PubMed ID: 22846988
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial-targeted photosensitizer-loaded folate-albumin nanoparticle for photodynamic therapy of cancer.
Battogtokh G; Ko YT
Nanomedicine; 2017 Feb; 13(2):733-743. PubMed ID: 27815176
[TBL] [Abstract][Full Text] [Related]
11. Redox- and light-responsive alginate nanoparticles as effective drug carriers for combinational anticancer therapy.
Zhang C; Shi G; Zhang J; Niu J; Huang P; Wang Z; Wang Y; Wang W; Li C; Kong D
Nanoscale; 2017 Mar; 9(9):3304-3314. PubMed ID: 28225139
[TBL] [Abstract][Full Text] [Related]
12. Self-Quenched Polysaccharide Nanoparticles with a Reactive Oxygen Species-Sensitive Cascade for Enhanced Photodynamic Therapy.
Uthaman S; Kim Y; Lee JY; Pillarisetti S; Huh KM; Park IK
ACS Appl Mater Interfaces; 2020 Jun; 12(25):28004-28013. PubMed ID: 32501678
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy.
Lee SJ; Koo H; Jeong H; Huh MS; Choi Y; Jeong SY; Byun Y; Choi K; Kim K; Kwon IC
J Control Release; 2011 May; 152(1):21-9. PubMed ID: 21457740
[TBL] [Abstract][Full Text] [Related]
14. Graphene oxide-incorporated pH-responsive folate-albumin-photosensitizer nanocomplex as image-guided dual therapeutics.
Battogtokh G; Ko YT
J Control Release; 2016 Jul; 234():10-20. PubMed ID: 27164545
[TBL] [Abstract][Full Text] [Related]
15. A Light Responsive Nanoparticle-Based Delivery System Using Pheophorbide A Graft Polyethylenimine for Dendritic Cell-Based Cancer Immunotherapy.
Zhang C; Zhang J; Shi G; Song H; Shi S; Zhang X; Huang P; Wang Z; Wang W; Wang C; Kong D; Li C
Mol Pharm; 2017 May; 14(5):1760-1770. PubMed ID: 28296410
[TBL] [Abstract][Full Text] [Related]
16. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
Hwang HY; Kim IS; Kwon IC; Kim YH
J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
[TBL] [Abstract][Full Text] [Related]
17. Plasma membrane activatable polymeric nanotheranostics with self-enhanced light-triggered photosensitizer cellular influx for photodynamic cancer therapy.
Jia HR; Jiang YW; Zhu YX; Li YH; Wang HY; Han X; Yu ZW; Gu N; Liu P; Chen Z; Wu FG
J Control Release; 2017 Jun; 255():231-241. PubMed ID: 28442408
[TBL] [Abstract][Full Text] [Related]
18. Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics.
Min HS; You DG; Son S; Jeon S; Park JH; Lee S; Kwon IC; Kim K
Theranostics; 2015; 5(12):1402-18. PubMed ID: 26681985
[TBL] [Abstract][Full Text] [Related]
19. Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models.
Na JH; Koo H; Lee S; Min KH; Park K; Yoo H; Lee SH; Park JH; Kwon IC; Jeong SY; Kim K
Biomaterials; 2011 Aug; 32(22):5252-61. PubMed ID: 21513975
[TBL] [Abstract][Full Text] [Related]
20. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
